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The  tick  Rhipicephalus  (Boophilus)  microplus  is  one  of  the  most  important  bovine  ectopar-
asites,  a  disease  vector  responsible  for losses  in  meat  and  milk  productions.  A  cysteine
protease  similar  to  cathepsin  L, named  BmCL1,  was  previously  identiﬁed  in  R.  microplus
gut, suggesting  a role  of  the  enzyme  in  meal  digestion.  In  this  work,  BmCL1  was  success-
fully  expressed  in  Pichia  pastoris  system,  yielding  54.8  mg/L  of  culture  and its  activity  was
analyzed by  synthetic  substrates  and  against  a R. microplus  cysteine  protease  inhibitor,ysteine proteases
hipicephalus (Boophilus) microplus
rotein expression
nzyme kinetic
hage  display library
Bmcystatin.  After  rBmCl1  biochemical  characterization  it was  used  in  a selection  of a pep-
tide phage  library  to  determine  rBmCL1  substrate  preference.  Obtained  sequenced  clones
showed that  rBmCL1  has  preference  for Leu  or  Arg  at P1 position.  The  preference  for Leu at
position  P1 and  the  activation  of  BmCL1  after  a Leu  amino  acid  residue  suggest  possible  self
activation.. Introduction
The tick Rhipicephalus (Boophilus) microplus is one of
he  most important bovine ectoparasites, a disease vector
eld  responsible for the transmission of diseases such as
abesiosis and anaplasmosis, which cause massive losses
n  livestock production (Sauer et al., 1995). Once attached
o  a bovine, R. microplus is able to ingest a large volume of
lood,  in a process that increases its body weight by more
han  50 times, when compared with its original weight,
ost intensely during the last 24 h of engorgement. Blood
igestion in ticks is an intracellular process via phagocy-
Abbreviations: rBmCL1, recombinant Boophilus microplus cathep-
in L-Like; Kcat, turnover number; Ki , inhibition constant; Km,
ichaelis–Menten constant; Vmax, maximum velocity.
∗ Corresponding author. Tel.: +55 11 55764445; fax: +55 11 55723006.
E-mail address: tanaka.bioq@epm.br (A.S. Tanaka).
304-4017©  2011 Elsevier B.V. 
oi:10.1016/j.vetpar.2011.04.003
Open access under the Elsevier OA license.© 2011 Elsevier B.V. 
tosis by desquamated epithelial cells in the midgut (Koh
et  al., 1991; Sonenshine, 1991). Recently, Lara et al. (2005)
showed that the midgut digestive cells endocytose blood
components and release large amounts of heme during
hemoglobin digestion. Proteolytic enzymes secreted in the
tick  midgut may  be required for various functions that
are  essential to tick survival via blood feeding behavior
(Ribeiro, 1987), and play critical roles in pathogen trans-
mission (Tsuji et al., 2008). Thus, proteolytic enzymes may
become  interesting candidates as drug targets and a com-
ponent  of vaccines for both tick and tick-borne disease
controls (Rand et al., 1989; Renard et al., 2002; Willadsen
and Kemp, 1988). Among the tick proteolytic enzymes, sev-
eral  cysteine proteases belonging to the papain superfamily
have been identiﬁed (Estrela et al., 2007; Renard et al., 2000,
Open access under the Elsevier OA license.2002;  Seixas et al., 2003; Tsuji et al., 2008). Cysteine pro-
teases  are expressed in organisms from bacteria to humans.
In  parasites it has been suggested that cysteine proteases
are involved in the invasion of host tissues and evasion of
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the host immune system (reviewed in McKerrow (1989)
and  Roche et al. (1999)). In hematophagous organisms,
cysteine proteases have been described as responsible for
hemoglobin digestion in the gut of Schistosoma mansoni
(Brady et al., 1999) and in the vacuole of the Plasmod-
ium falciparum (Salas et al., 1995). In the R. microplus
tick, cathepsin L-like enzymes have been found in the
midgut and eggs, which suggests the involvement of these
enzymes in meal digestion (Renard et al., 2002) and in
vitellin degradation (Estrela et al., 2007; Seixas et al., 2003),
respectively.
Previously, Renard et al. (2000) cloned and expressed an
R.  microplus cathepsin L-like enzyme named BmCL1. The
recombinant enzyme was able to hydrolyze natural sub-
strates  such as tick vitellin, bovine hemoglobin and gelatin
at  acidic pH. Moreover, it was shown that the BmCL1 tran-
script  is expressed in partially engorged tick females, and
that  the enzyme seems to be localized in secretory gut cells.
Taking  all these observations together, the authors postu-
lated  that BmCL1 may  be involved in bovine hemoglobin
degradation in the R. microplus gut (Renard et al., 2002).
Recently, it was shown that bovine hemoglobin degrada-
tion by BmCL1 generates potential antimicrobial peptides
based  on human and bovine hemocidins (Cruz et al., 2010).
Various  methods have been used to identify drug tar-
gets  for parasite control (Canales et al., 2009), among which
combinatorial mutated peptides or proteins displayed on
ﬁlamentous bacteriophage surface, which is known as
phage  display system, have evolved as an important tool
to  study protein– or peptide–protein interactions (Smith,
1985). Phage display libraries have been used to select spe-
ciﬁc  protease inhibitors (Campos et al., 2004; Markland
et al., 1996a, 1996b; Roberts et al., 1992; Tanaka et al.,
1999), to increase the anticoagulant activity of proteins
(Maun et al., 2003; Yang et al., 2002), and to select spe-
ciﬁc  antibodies (Barbas et al., 1991; Marks et al., 1991).
In  addition, peptide phage display libraries have also
been successfully employed to deﬁne enzyme substrates
(Deperthes, 2002; Matthews and Wells, 1993).
In the present work, we cloned and highly expressed
the active BmCL1 (rBmCL1) enzyme using the Pichia pas-
toris  system. The puriﬁed rBmCL1 enzyme was used in
biochemical characterization and in substrate speciﬁcity
investigation using a peptide phage display library.
2. Materials and methods
2.1.  Materials
The pPIC9 vector and P. pastoris strain GS115 were pur-
chased from Invitrogen Corporation (Carlsbad, CA, USA)
and  used following the supplier’s instructions. Media com-
ponents  were from Difco (Detroit, MI,  USA). Restriction
endonucleases and T4 DNA ligase were obtained from Fer-
mentas  (Beverly, Vilnius, Lithuania). Taq DNA polymerase
was obtained from Promega Corporation (Madison, WI,
USA);  Oligonucleotides were synthesized by Invitrogen
(Carlsbad, CA, USA). All other reagents were obtained from
Sigma  (St. Louis, MO,  USA). DNA sequencing was per-
formed using DYEnamicTM ET Dye Sequencing kit from
Amersham Little Chalfont (Buckinghamshire, England, UK)ology 181 (2011) 291– 300
on  an ABI377 sequencer from Applied Biosystems (Fos-
ter  City, CA, USA). Amicon Ultra 5000 MWCO  membrane
was  from Millipore (Billerica, MA,  USA), and the HiTrap
SP  column was from Amersham Biosciences (Piscataway,
NJ, USA). The substrates: Bz-Phe-Arg-pNa, Z-FR-MCA, Z-
RR-MCA  (MCA = methyl-7-aminocoumarin amide) and the
inhibitor  E-64 ([trans-epoxy-succinyl-l-leucylamido-(4-
guanidino)butane]) were purchased from Sigma (St. Louis,
MO,  USA). The substrate Z-LR-MCA was  from Novabiochem
(Darmstadt, Germany).
2.2.  Transcription analysis of BmCL1 by PCR
The cDNA sequence encoding BmCL1 was  ampliﬁed
using cDNA prepared of mRNA from ovary, fat body,
salivary gland, gut, and haemocytes of R. microplus
engorged adult females. The PCR was performed using
two  speciﬁc primers, the sense primer BmCL1fw (5′-
GTATCTCTCGAGAAAAGATCTCAAGAAATCCTACGCACC-3′)
and the antisense primer BmCL1rv (5′-
CCCGTGCGGCCGCTTAGACGAGGGGGTAGC-3′). The PCR
was  performed in 50 L reaction volume containing 1 L
of  cDNA sample, 25 pmol of each primer, 100 M dNTPs,
1.5 mM MgCl2, and 2.5 U Taq DNA polymerase (Fermentas,
Vilnius, Lithuania). The control of DNA ampliﬁcation was
made  using 25 pmol of R. microplus actin speciﬁc primers:
Actf (5′-TCCTCGTCCCTGGAGAAGTCGTAC-3′) and Actr
(5′-CCACCGATCCAGACCGAGTACTTC-3′). PCR conditions
were: 94 ◦C for 5 min; 25 cycles (94 ◦C–40 s, 62 ◦C–40 s,
72 ◦C–1 min), 72 ◦C for 5 min.
2.3. BmCL1 DNA fragment ampliﬁcation and cloning into
pPIC9  vector
The  DNA fragment encoding the BmCL1 gene was ampli-
ﬁed  by PCR using a plasmid construct containing the BmCL1
coding  sequence in vector pMAL-p as template (Renard
et  al., 2000). The PCR was performed using a primer set
constructed based on the BmCL1 coding region sequence,
introducing restriction sites for Xho I and Not I enzymes at
5′ and 3′ ends, respectively. The sense oligonucleotide was:
5′-CTC GAG GTA TCT CTC GAG AAA AGA TCT CAA GAA ATC
CTA  CGC ACC-3′, while the antisense was: 5′-GC GGC CGC
CCC  GTG CGG CCG CTT AGA CGA GGG GGT AGT-3′. PCR
reaction conditions were conducted in a ﬁnal volume of
50  L, 1.5 mM MgCl2, 100 M dNTPs, 10 pM of each primer,
5  U of Taq DNA polymerase, and its corresponding buffer
(100  mM Tris–HCl pH 8.8, 500 mM KCl, and 0.8% (v/v) Non-
idet  P40). The PCR parameters were: pre-denaturation at
94 ◦C for 2 min; 30 cycles of (94 ◦C for 30 s, 55 ◦C for 45 s,
72 ◦C for 1 min); followed by 5 min  at 72 ◦C. BmCL1 DNA
fragment band was separated by agarose gel electrophore-
sis 1% (w/v) and puriﬁed from agarose gel using QIAquick
Gel  Extraction kit from QIAGEN (Hilden, Germany). Puriﬁed
DNA  fragment was  digested with Xho I and Not I restriction
enzymes, followed by ligation to pPIC9 vector, which was
previously digested with the same enzymes, generating
the BmCL1-pPIC9 construction. Escherichia coli DH5 was
transformed using the construction and plated on Lenox
Broth  (LB) agar plates (1% tryptone, 0.5% yeast extract,
0.5% NaCl, pH 7.0) containing 200 g/mL ampicillin. Correct
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nsertion of PCR fragment was veriﬁed by DNA sequenc-
ng. One correct construction (BmCL1-pPIC9) was used in a
idi-plasmid DNA preparation using Plasmid Midi Kit from
IAGEN  (Hilden, Germany). BmCL1 deduced amino acid
equence was aligned with other cathepsin L-like cysteine
roteases using ClustalW program.
.4. Transformation of P. pastoris yeast
P. pastoris GS115 strain was grown in a yeast
xtract-peptone-dextrose (YPD) medium and prepared for
ransformation by electroporation following the manu-
acturer’s instructions. After linearization of the plasmid
mCL1-pPIC9 (10 g) with Nsi I restriction enzyme, compe-
ent  P. pastoris GS115 was transformed by electroporation.
east transformation was performed in a 0.2-cm cuvette
n  a Gene Pulser (Bio-Rad, Hercules, CA) using the follow-
ng  parameters: 1.5 kV, 25 F and 400 . The eletroporated
ells were immediately suspended in 1.0 mL  of ice-cold
.0 M sorbitol and spread on MD  agar plate (1.34% YNB, 2%
extrose,  4 × 10−5% biotin) without histidine. Clones that
ere  homologous recombinants with the AOX I sequence
ere selected. After incubation at 30 ◦C for 48 h, the clones
ere  transferred to an MD  agar plate without histidine to
creen  for methanol utilization plus (Mut+). The target gene
n  the recombinants was detected by PCR reactions using
′ and 5′AOX primers from Invitrogen (Carlsbad, CA, USA).
.5.  Selection of yeast clones functional expressing
mCL1
To identify positive yeast clones, ﬁve isolated P. pastoris
S115 strains carrying BmCL1 gene fragment, conﬁrmed by
CR  reaction, were individually inoculated in 5 mL  BMGY
edium (1.0% yeast extract, 2.0% peptone in 100 mM
otassium phosphate buffer pH 6.0, 1.34% YNB 4 × 10−5%
w/v)  D-biotin and 1% (v/v) glycerol) in a 50-mL sterile
ube, and cultivated at 30 ◦C for 28 h at 250 rpm. The yeast
ells  were harvested by centrifugation at 3000 g for 5 min
t  4 ◦C, and cells were resuspended in BMMY  (1.0% yeast
xtract, 2.0% peptone in 100 mM potassium phosphate
uffer at pH 6.0, 1.34% YNB 4 × 10−5% (w/v) D-biotin and
.5% (v/v) methanol) medium to absorbance at 600 nm
f  1.0, following expression for 4 days at 30 ◦C, shaking
t 250 rpm. The protein expression was induced every
4  h by adding 0.5% methanol to the yeast cultures. After
ermentation, yeast cells were removed by centrifugation
4000 × g for 20 min  at 4 ◦C) and the supernatants were
sed in enzymatic activity detection by chromogenic
ubstrate (HD-Pro-Phe-Arg-pNa) hydrolysis. Analysis of
ndividual  clones showed the same expression level for all
hecked  clones (data not shown).
.6. Expression of rBmCL1
One  isolated P. pastoris colony (Mut+) expressing
mCL1 in high level was inoculated in 50 mL  BMGY
edium in 1 L sterile ﬂask, and cultivated at 30 ◦C for
4  h at 250 rpm. The yeast cells were harvested by cen-
rifugation at 3000 × g for 5 min  at 4 ◦C, and cells were
esuspended in BMMY  medium to absorbance at 600 nmology 181 (2011) 291– 300 293
of  1.0, following expression for 4 days at 30 ◦C, shaking at
250  rpm. The protein expression was  induced after every
24  h by adding 0.5% methanol to the yeast culture. After
fermentation, yeast cells were removed by centrifugation
(4000 × g for 20 min  at 4 ◦C) and the supernatant was
stored at 4 ◦C for puriﬁcation procedure.
2.7.  Puriﬁcation of recombinant BmCL1
Recombinant BmCL1 secreted to the yeast supernatant
was pre-activated by dialysis in 40 mM sodium acetate
buffer, pH 5.5, for 12 h at 4 ◦C. After dialysis, the super-
natant was  ﬁltered in 0.45-m ﬁlter and BmCL1 puriﬁed
by ion exchange chromatography in a HiTrap SP (5 mL)  col-
umn  connected to an ÄKTA puriﬁer chromatograph. The
supernatant (400 mL)  was  applied to a HiTrap SP column
pre-equilibrated with 50 mM sodium acetate buffer, pH 5.5.
After  the washing step, the adsorbed proteins were eluted
by  a linear NaCl gradient (0–1 M)  at ﬂow rate 1 mL/min. The
proteins  elution was  monitored by absorbance at 280 nm. A
major  protein peak was detected at approximately 400 mM
NaCl.  Fractions were analyzed by chromogenic substrate
hydrolysis and by SDS-PAGE (12%). The fractions containing
proteolytic activity and presented one main protein band
were  pooled and concentrated using a membrane Amicon
Ultra  5000 MWCO  from Millipore (Billerica, MA,  USA).
2.8.  SDS-PAGE
SDS-PAGE was performed according to Laemmli (1970).
12%  SDS-PAGE with 5% stacking gel was  used to analyze
rBmCL1. Proteins were stained by Coomassie Brilliant Blue
R-250  solution.
2.9.  Enzymatic activity assay
The rBmCL1 activity was measured using the chro-
mogenic substrate Bz-Phe-Arg-pNa (Sigma) or HD-Pro-
Phe-Arg-pNa (Chromogenix) (Erlanger et al., 1961). The
samples  were pre-incubated at 37 ◦C for 10 min  in 0.1 M
sodium acetate buffer pH 5.5, containing 1 mM DDT. Then
the  substrate (0.2 mM)  was  added and the enzyme activ-
ity  was monitored by measuring the absorbance at 405 nm
in  a plate reader Synergy HT model (Biotek, Winooski,
USA). The speciﬁc cysteine protease inhibitor E-64 (L-
trans-epoxy-succinyl-leucylamido-[4-guanidino] butane)
was  used to determine the rBmCL1 active concentra-
tion by active site titration. The enzyme was  activated
by pre-incubation with 1% DTT in acid medium, fol-
lowing incubation with different concentrations of E-64,
and  ﬁnally the activity was  monitored by adding chro-
mogenic substrate, as described above. The experiments
with human cathepsin L and cathepsin B were performed
using the same method.
2.10.  Determination of kinetic parameters of rBmCL1The enzyme assays were done with the substrates Z-
FR-MCA, Z-RR-MCA and Z-LR-MCA. The experiments were
performed in a Hitachi F-2500 spectroﬂuorometer. The
assays  were performed in 0.1 M sodium acetate buffer, pH
294 R.O. Clara et al. / Veterinary Parasitology 181 (2011) 291– 300
Fig. 1. Virion particle scheme used for peptide phage library construction. It is represented by the virion particle and its protein composition, with the
single  strand DNA inside. As shown, the monovalent system was used and the N-terminal of protein gIII was fused to 6 random amino acids followed by a
histidine  tag.
Table  1
Yield  and quality of rBmCl1 expressed in the Pichia pastoris system.
Sample
volume (L)
Proteina
(mg/mL)
Total
protein
(mg)
Active
protease
(mg/mL)
Total  active
protease
(mg)
Speciﬁc  activity
(active mg/
protein  mg)
Recovery (%) Yield
(fold)
Yeast supernatant 1 1.33 1330.0 0.0548 54.80 0.041 100.0 1
0.639
1.630HiPrep SP P1 8.0 2.40 19.2 
HiPrep SP P2 12.0 3.20 38.4 
a Protein quantiﬁcation using the Bradford method (Bradford, 1976).
5.0, at 37 ◦C. BmCL1 was  pre-activated in the presence of
2  mM DTT for 5 min  at 37 ◦C before the addition of the
substrates. The ﬂuorescence changes were continuously
monitored at ex = 380 nm and em = 460 nm.  The appar-
ent second order rate constant kcat/Km was determined
under pseudo ﬁrst-order conditions, where [S]  Km and
performed at two different substrate concentrations and
calculated by a non-linear regression Graﬁt program. In all
determinations, the errors were less than 5%.
2.11. pH activity proﬁle
The  rBmCL1 optimum pH curve activity was performed
at 37 ◦C using Z-FR-MCA as substrate. We  used a four-
component buffer containing 25 mM glycine, 25 mM acetic
acid,  25 mM Mes, and 75 mM Tris (3.0 < pH < 8.0). rBmCL1
was pre-activated with 2 mM DTT for 5 min  at 37 ◦C
before adding the substrate. For each pH, the apparent
second-order rate constant (kcat/Km) was determined at
low  substrate concentrations, where the reaction followed
the  ﬁrst-order conditions ([S]  Km).
Fig. 2. BmCL1 transcription analysis. RNA preparations of salivary gland
(SG), fat body (FB), gut, ovary (OV) and haemocytes (H) of R. microplus
engorged adult females and speciﬁc primers of BmCL1 were used in PCR
analysis. Actin speciﬁc primers were used as control. 5.11 0.266 9.3 6.5
 19.56 0.509 35.7 12.4
2.12. Determination of inhibition constant (Ki)
The inhibition constant of Bmcystatin (Lima et al., 2006)
for  rBmCL1 was  determined using the ﬂuorogenic sub-
strate  Z-FR-MCA. Brieﬂy, the enzyme was  pre-activated
in 0.1 M sodium acetate buffer, pH 5.0, containing 1 mM
DTT  for 5 min  at 37 ◦C and then pre-incubated with Bmcys-
tatin  (0.2–0.7 M)  for 10 min  before adding Z-FR-MCA
(10 M).  The residual enzyme activity was  continu-
ously monitored by ﬂuorescence changes at ex = 380 nm
and  em = 460 nm.  The inhibition constant (Ki) was
calculated by ﬁtting the steady-state velocities to the equa-
tion  (Vi/Vo = 1 − {Et + It + Ki − [(Et + It + Ki)2 − 4EtIt]1/2}/2Et)
for tight-binding inhibitors using a non-linear regression
analysis (Morrison, 1969).
2.13.  Peptide mutant phage display library construction
The library was designed with random mutation in
six  positions. Initially, a PCR reaction was performed
with a mutated oligonucleotide as template (PEPTN: 5′-
CTTTCTATGCGGCCCAGCCGGCCAGCCATCATCATCATCATC-
ATCATGGAGCAGCNNSNNSNNSNNSNNSNNSGCGGCCGC-
TTTTCCTTG-3′ – N = A/T/C/G; S = G/C) to achieve polymer-
ized double strand randomized DNA. The random DNA
template obtained was puriﬁed and digested with Sﬁ I and
Not  I restriction enzymes, which have sites in the cloning
region of vector pCANTAB 5E (Amersham Biosciences).
DNAs of interest were ligated downstream the g3p signal
sequence at pCANTAB 5E, previously digested by the same
restriction enzymes. Variable designed plasmids were
electroporated in competent TG1 E. coli strain and the titer
of  the obtained library was  measured (Tanaka et al., 1999).
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Fig. 3. Alignment of BmCL1 (access number AF227957) amino acid sequence with other cathepsin L-like proteases from tick Dermacentor variabilis (DvCL)
(access  number EU025855), Rhipicephalus appendiculatus (RaCL) (access number AY208824), Ixodes ricinus (IrCL) (access number EF428205), and human
H  acid seq
u e seque
b
2
(
g
T
Komo  sapiens (CathL1) (access number NM 001912). Signal peptide amino
nderlined. The amino acid residues which appear at least in three enzym
y  a black box.
.14. Peptide library selection for recombinant BmCL1After the titration of peptide phage display library
9.0 × 106 CFU total), E. coli TG1 transformed cells were
rown in 2YT medium containing 200 g/mL ampicillin
able 2
inetic parameters for the hydrolysis of ﬂuorogenic substrates by BmCL1 and oth
Substrate rBmCL1 Cathepsin La
kcat (s−1) Km (M) kcat/Km
(mM−1 s−1)
kcat (s−1) Km
Z-FR-MCA 11.0 0.3 36,700 10.3 2
Z-LR-MCA 3.0 0.12 25,000 – –
Z-RR-MCA b b b 0.22 51
a Melo et al. (2001).
b rBmCL1 concentration used was 10 times higher than the other substrates.uences are boxed. Amino acid residues of putative BmCL1 pro-peptide are
nces are shadowed. The catalytic triad amino acid residues are identiﬁed
and 2% glucose until an optical density of A550 = 0.5–0.7 was
reached, after which helper phage (M13K07) with a mul-
tiplicity of infection of 50 was added in order to produce
fusion phages, as described in the manufacturer’s guide.
The  culture was  centrifuged and the medium was replaced
er cysteine proteases.
Cathepsin Ba
(M) kcat/Km
(mM−1 s−1)
kcat (s−1) Km (M) kcat/Km
(mM−1 s−1)
.0 5150 75.9 23.4 3243
 – – – –
.0 4.3 18.0 82.0 220.0
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Fig. 4. Puriﬁcation and characterization of recombinant BmCL1. (A) Ion exchange chromatography of supernatant containing rBmCL1 on HiTrap SP column.
After  expression, yeast cells were harvested and the supernatant submitted to an ion-exchange chromatography in HiTrap SP column. Yeast supernatant
containing  rBmCL1 was  dialyzed against 50 mM sodium acetate buffer pH 5.5 and it was  applied to the column pre-equilibrated with the same buffer. After
buffer p
of puriﬁ
k arrowthe  washing step, the proteins were eluted with 50 mM sodium acetate 
fractions  selected for pools P1 and P2, respectively. (B) SDS-PAGE (12%) 
HiTrap  SP column. 2. Peak P2 of rBmCL1 after HiTrap SP column. The blac
by 2YT containing 200 g/mL ampicillin and 50 g/mL
kanamycin and incubated for 15 h, at 37 ◦C. Next, fusion
phage particles released in the supernatant were sepa-
rated  from the bacterial pellet by centrifugation. Fusion
phage solution was used for four rounds of selection. The
phage  particle construction is represented in Fig. 1. The
constructed fusion phage particles express HisTag at pro-
tein  III N-terminal that afforded phage afﬁnity binding to
Ni-NTA  magnetic agarose beads (GE). A 500-L aliquot of
Table 3
Inhibition constant (Ki) of Bmcystatin for different cysteine proteases.
Ki (nM)
rBmCL1 Cathepsin L Cathepsin B
Bmcystatin 370 0.1a 80a
Ca 074 n.i. 233,000b 1.94b
n.i.: not inhibited until the concentration of 1 M.
a Lima et al. (2006).
b Towatari et al. (1991).H 5.5 containing 1 M NaCl. The black lines show the proteolytic activity
ed rBmCL1. MM.  Molecular weight standard. 1. Peak P1 of rBmCL1 after
 shows protein band around 27 kDa.
the supernatant containing fusion phages was  incubated
with 30 L of agarose Ni-NTA for 6 h in a tube mixer at room
temperature. Subsequently, the beads were centrifuged
and washed seven times with 50 mM Tris–HCl buffer, pH
8.0,  containing 20 mM imidazole and 100 mM  NaCl. At this
moment,  rBmCL1 was added and incubated for 1 h at 37 ◦C.
rBmCL1  cleaved peptides were released in the supernatant
and 1 M E64 was added to avoid the cleavage of selected
phage particle proteins. The eluted phages were used to
transfect  new E. coli TG1 strain at A550 = 0.5–0.7 to amplify
these selected phages for another round of selection. At this
step,  in every round of selection the number of selected
phages was  determined by titration.
3. Results and discussion3.1.  Transcription analysis of BmCL1 by PCR
BmCL1 gene speciﬁc primers were used in RT-PCR to
analyze the transcription in different tissues from fully
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Table 4
Selected peptide sequences for rBmCL1 using a peptide phage display library.
Sequence Occurrence
Sequenced clones
G N Q V E L A A A G A 15
S S V W V R# S A A  A P 6
G S S A V R # G Q G A P 6
H G S S L L* Q V S  A A 6
H G S S L L * Y V S A A 5
H H G S S R# T L L G E 5
S S R E L R# G G A A A 3
G S S K L L * K S A A A 3
H H G S S L Q V S N  W 3
C P G V L R# A A A P A 2
S S G A V L G A  A A A 2
Sequences not showed**
*Leu-Leu (appeared in more :) 6
&Single Leu (appeared in more:) 5
#Arg (appeared in more:) 6
**Selected peptide sequences with few recurrence that presents the same observed data in the most repetitive clones.
*Sequences containing Leu–Leu represent around 25% of all the selected peptide sequences.
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eSequences with one Leu residue represent around 30% of all selected pe
Sequences containing Arg represent around 28% of all the selected pepti
ngorged females using total RNA as template. The BmCL1
ranscript in ovary, fat body, salivary gland, gut and hemo-
ytes  of R. microplus engorged adult females was  analyzed
Fig.  2), and the BmCL1 transcription was identiﬁed only
n  the gut, reinforcing its importance in digestion (Renard
t  al., 2002). The RNA samples integrity was conﬁrmed
sing actin speciﬁc primers, as control.
.2. Cloning, expression, puriﬁcation and biochemical
haracterization of rBmCL1
Previously, a cysteine protease similar to cathepsin
 from R. microplus, named BmCL1 was cloned and
xpressed in E. coli (Renard et al., 2000, 2002). The
ecombinant BmCL1 was able to hydrolyze natural sub-
trate  such as hemoglobin and also synthetic substrates
Renard et al., 2002). BmCL1 expression was localized
n the gut cells of ticks, suggesting that it can be a
romising target to be used for R. microplus control
Renard et al., 2002). In an attempt to produce a large
mount of BmCL1, the DNA fragment encoding for BmCL1
GenBank: AAF61565) was cloned into pPIC9 expression
ector. The construction pPIC9-BmCL1 (10 g) was lin-
arized and used in the methylotrophic yeast P. pastoris
ransformation. Several clones were tested for rBmCL1
xpression.quences.
ences.
Several clones of P. pastoris carrying BmCL1 DNA
fragment were cultivated for rBmCL1 secretion to the
supernatant. All cell-free culture media were analyzed by
SDS-PAGE  and presented a predicted 28 kDa protein band,
which  was not present in the medium before methanol
induction. Among the different clones producing rBmCL1,
the  one expressing the largest amount of active enzyme
was chosen to scale up protein expression. The active
rBmCL1 expression level was  54.80 mg/L, being higher than
that  expressed by E. coli (Renard et al., 2000). BmCL1
expression was  comparable to other cysteine protease
expressed in the P. pastoris system (Aoki et al., 2003; Chan
et  al., 1999; Linnevers et al., 1997).
BmCL1 amino acid sequence is similar to other
cathepsin-L like cysteine proteases, but its identity is higher
to  other ticks cathepsin L-like proteases (Fig. 3). rBmCL1
contains the conserved motif among cysteine proteases,
GCNGG, retaining the central asparagine residue as the
single  variant, which is exchanged for glutamic acid in
BmCL1.  This also occurs with the ticks Dermacentor vari-
abilis  (DvCL), Rhipicephalus appendiculatus (RaCL), Ixodes
ricinus  (IrCL) amino acid sequences, where the suggested
function for this motif would be structural role. Moreover,
rBmCL1 presents the Cys, His and Asn conserved residues
involved in the catalysis and six cysteine residues proba-
ble  responsible for disulﬁde bonds formation (Renard et al.,
2000).
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The rBmCL1 secreted to the P. pastoris medium was puri-
ﬁed  by one chromatography step in a HiTrap SP column
(Fig. 4A). Active rBmCL1 was fractionated in two peaks,
named P1 and P2, yielding 5.11 mg  and 19.56 mg  puriﬁed
enzyme, respectively that displayed the same N-terminal.
rBmCL1 P2 showed higher enzymatic recovery and puriﬁ-
cation  (35.7% and 12.4-fold, respectively; Table 1). Both P1
and  P2 showed a major protein band of about 28 kDa, but
several  lower protein bands were detected in a SDS-PAGE,
which suggested degradation process
Puriﬁed rBmCL1 of P1 fraction presented high speciﬁc
activity was used in kinetic assays. The apparent second
order rate constant kcat/Km of rBmCL1 for two  different
substrates was  determined and compared to that obtained
for  cathepsin L and cathepsin B (Table 2). Z-FR-MCA
was cleaved by rBmCL1 (kcat/Km = 36,700 mM−1 s−1),
cathepsin L (kcat/Km = 5150 mM−1 s−1) and cathep-
sin B (kcat/Km = 3243 mM−1 s−1), while Z-LR-MCA was
hydrolyzed only by rBmCL1(kcat/Km = 25,000 mM−1 s−1)
and Z-RR-MCA was poorly hydrolyzed by cathep-
sin L (kcat/Km = 4.3 mM−1 s−1) and cathepsin B
(kcat/Km = 220.0 mM−1 s−1), and not at all by BmCL1.
These results indicated substrate selectivity between
these enzymes. The BmCL1 kcat/Km relationship for Z-
FR-MCA hydrolysis was 1.5-fold higher than that for the
hydrolysis the Z-LR-MCA.
In  inhibitory assays, BmCL1, cathepsin L and cathepsin
B were tested with Bmcystatin, a cystatin from R. microplus
(Lima et al., 2006) and CA-074, a irreversible cathepsin B
inhibitor  (Table 3). Bmcystatin was able to inhibit BmCL1,
cathepsin L and B, with Ki in nM range, indicating that
BmCL1 can be one target of the natural cystatin of R.
microplus tick, controlling its excessive proteolytic activity.
Previously, Towatari et al. (1991) had shown that CA-074
inhibited cathepsin L and cathepsin B with Ki value of
23.3  nM and 1.94 nM,  respectively; however, CA-074 was
not  able to inhibit BmCL1.
The  rBmCL1 optimum pH determination was performed
at  37 ◦C using a four-component buffer over a pH range
of  3.0–7.0 (Fig. 5) and the second-order rate constant
was determined. rBmCL1 optimum pH was 5.5, conﬁrming
its  similarity to the expressed enzyme by E. coli (Renard
et  al., 2002). These ﬁndings are consistent with verte-
brate cathepsins and also with BmCL1 role in the digestion
process, which may  occur in acid pH of the intestine envi-
ronment (Lara et al., 2005).
3.3.  Selection of substrate for rBmCL1 using a peptide
phage display library
The  random sequence (His)6(Gly)1(Ser)2(X)6 was  fused
to  M13  protein 3 gene at the phagemid pCANTAB-5E. The
constructed peptide phage library title was 9.0 × 106 CFU.
To  analyze the efﬁciency of input phages coupling on
the  beads, the library titer was calculated before and
after incubation with beads, presenting 4.6 × 1012 CFU
and 1.43 × 1011 CFU, respectively, which indicates that
97% of the fusion phages were bound to the beads.
After the 3rd round of selection, the phage enrich-
ment for rBmCL1 was  83 times higher than in the
2nd round. Taken together, these results demonstrateFig. 5. Optimum pH curve for rBmCL1. The highest proteolytic activity
was  considered to be 100%. The assay was performed using Z-FR-MCA as
substrate.
robustness of phage display as a method for substrate selec-
tion.
The  knowledge of protease speciﬁcity can help to iden-
tify  biological substrates and guide the design of speciﬁc
inhibitors (Uhlen and Moks, 1990). In order to understand
BmCL1 substrate speciﬁcity we sequenced 100 phagemids
selected for BmCL1 and the translated peptide sequences
were aligned in a weblogo analysis program (Crooks et al.,
2004)  (Fig. 6). Analysis of the 100 phagemids indicates that
charged  amino acids and non-polar amino acids appear
frequently at the six mutated positions, corroborating pre-
vious  reports that rBmCL1 has a preference for these amino
acids  at position P1 and P2 (Cruz et al., 2010). Of signif-
icance was  the presence of Leu at all six positions, while
Arg  was  the next most frequently observed amino acid.
This  result suggests that rBmCl1 may  cleave after Leu or
Leu–Leu  residue, and this could be the processing site for
intestinal proteins, i.e. BmTIs (Sasaki et al., 2004; Sasaki and
Tanaka,  2008). N-terminal sequencing of rBmCl conﬁrmed
that  rBmCL1 is cleaved at 106L/PPA, which is in contrast to
the  115S/LPK sequence proposed by Renard et al. (2000).
rBmCL1 preferred non-polar residues at position P2
using hemoglobin as substrate (Cruz et al., 2010). This data
corroborates our ﬁndings in which if Gln, Arg, Leu or Glu
are  ﬁxed at P1 position, non-polar residues represents 60%
of  all determined sequences (Table 4). On the other hand,
when  merely Arg is ﬁxed at position P1, rBmCL1 has a pref-
erence  for uncharged amino acid residues (mainly Val or
Leu)  at position P2 (Table 4). Another relevant data of this
study  was  the high frequency of Leu–Leu residues which
may  indicate other role for BmCL1 besides its involvement
in protein digestion.
The  diversity of selected peptides and the fact that
BmCL1 is expressed only in gut cells suggests that this cys-
teine  protease is an essential digestive enzyme, cleaving
not  only hemoglobin, but also other main blood proteins.
As  published by Renard et al. (2000), BmCL1 was unable to
digest  native bovine serum albumin, but after BSA reduc-
tion  and carboxymetylation, BmCL1 generated different
peptide sequences (data not shown), which conﬁrms the
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Big. 6. Weblogo representation of amino acid recurrence at the six mutate
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ypothesis that BmCL1 is a digestive enzyme. Hydrolysis of
emoglobin  by gut cells generates hydroxyl radicals in the
ut  (Citelli et al., 2007), and in this environment the plas-
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y  rBmCL1.
In  conclusion, we showed a high rBmCL1 expression
evel by yeast P. pastoris. Also, it was observed that its
uriﬁcation will afford the production of large amount of
uriﬁed  rBmCL1 to be used in bovine immunization and
rystallization experiments. Moreover, we described the
rst  substrate phage display selection for a cysteine pro-
ease,  determining its cleavage sites preference, reinforcing
he  hypothesis that rBmCL1 is a potent digestive enzyme
f  R. microplus but also can play another important role in
he  tick physiology.
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